At 8.6% CAGR, Asia Pacific PCR Technologies Market is Projected to be Worth US$ 5,465.60 Million by 2030, says Business Market Insights

According to Business Market Insights research, the Asia Pacific PCR technologies market was valued at US$ 2,835.20 million in 2022 and is expected to reach US$ 5,465.60 million by 2030, registering a CAGR of 8.6% from 2022 to 2030. Increasing demand for POC testing and funds availability for PCR technologies are among the critical factors attributed to the Asia Pacific PCR technologies market expansion.

Point-of-care (POC) testing presents a significant opportunity for the PCR technology market by expanding its reach and applications. PCR technology, known for its accuracy and sensitivity, is increasingly being adapted for POC testing due to its ability to deliver rapid and reliable results at or near the point of care. As POC testing becomes more prevalent in healthcare settings such as clinics, emergency departments, and decentralized facilities, the demand for PCR platforms and assays tailored for POC applications is expected to rise. PCR's advantages, including the ability to detect infectious diseases with high specificity and sensitivity, make it well-suited for POC testing, particularly in situations requiring rapid diagnosis and treatment decisions. Additionally, the miniaturization and automation of PCR systems further enable their integration into POC settings, facilitating on-site testing and improving patient care outcomes. As healthcare providers increasingly recognize the value of POC PCR testing in enhancing diagnostic capabilities and patient management, the market for POC PCR technologies is poised for growth and innovation.

On the contrary, high costs of PCR systems and availability of alternative assay hampers the growth of Asia Pacific PCR technologies market.

Based on technology, the Asia Pacific PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held 38.5% share of Asia Pacific PCR technologies market in 2022, amassing US$ 1,092.96 million. It is projected to garner US$ 2,214.61 million by 2030 to expand at 9.2% CAGR during 2022-2030.

In terms of offerings, the Asia Pacific PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 59.1% share of Asia Pacific PCR technologies market in 2022, amassing US$ 1,677.00 million. It is projected to garner US$ 3,453.27 million by 2030 to expand at 9.4% CAGR during 2022-2030. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Asia Pacific PCR technologies market is categorized gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held 23.5% share of Asia Pacific PCR technologies market in 2022, amassing US$ 665.18 million. It is projected to garner US$ 1,369.15 million by 2030 to expand at 9.4% CAGR during 2022-2030.

Based on end user, the Asia Pacific PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held 56.6% share of Asia Pacific PCR technologies market in 2022, amassing US$ 1,603.63 million. It is projected to garner US$ 3,211.63 million by 2030 to expand at 9.1% CAGR during 2022-2030.

By country, the Asia Pacific PCR technologies market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 27.4% share of Asia Pacific PCR technologies market in 2022. It was assessed at US$ 776.23 million in 2022 and is likely to hit US$ 1,545.21 million by 2030, exhibiting a CAGR of 9.0% during 2022-2030.

Key players operating in the Asia Pacific PCR technologies market are Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd, among others.

• In February2023, Thermo Fisher Scientific Inc launched a complete set of PCR technologies in India. The company has launched PCR kits, which include Applied Biosystems Taq Path PCR kits for infectious diseases such as M. Tuberculosis complex (MTB); Hepatitis B Virus (HBV); Multi-Drug Resistant Tuberculosis (MTB MDR); Hepatitis C Virus (HCV); Human Immunodeficiency Virus (HIV); and for genetic analysis (HLA B27). The company has received licensing rights from the Central Drugs Standard Control Organization to manufacture in India in association with My lab Discovery Solutions.
  
  
• In February 2021, Thermo Fisher Scientific Inc announced the complete acquisition of Mesa Biotech Inc, a point-of-care molecular diagnostic company. The acquisition has allowed Thermo Fisher Scientific Inc to expand its portfolio with a point-of-care PCR-based testing platform for infectious disease diagnosis. And since 2021, Mesa Biotech Inc has become a part of the Life Sciences Solution Segment.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com